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Abstract
Background Implant rupture may be detected by physical examination, ultrasound or magnetic resonance imaging (MRI); the
majority of silicone implant ruptures are clinically undetectable. The absence of guidelines for behaviour in the face of a
suspected implant rupture often entails sending these patients for prosthetic revision surgery rather than carrying out in-depth
radiodiagnostics to confirm implant rupture. The aim of this paper is to report our multicentric experience, to indicate the correct
diagnostic-therapeutic procedure and to propose a model of informed consent.
Methods We conducted a multicentric retrospective analysis of 183 women submitted to prosthetic revision surgery due to
radiological diagnosis of suspected implant rupture after breast augmentation or post-mastectomy reconstruction, admitted to
three different Plastic Surgery Departments between 2002 and 2018. We correlated surgical findings with purpose of examina-
tion, symptoms, physical examination, imaging and device specifications.
Results Two hundred and twenty-one explanted implants were preoperatively suspected as ruptured. One-third were intact and
unjustifiably explanted. US associated with MRI evaluation was the most accurate method. Patient’s age, comorbidities,
smoking, medications, symptoms presented, implant duration and volume did not correlate with implant rupture.
Conclusions Our study confirms that the association of US andMRI represents the mode of diagnosis with fewest false positives.
Given the high number of errors associated with suspected intracapsular implant rupture, it seems necessary to submit an
appropriate and specific informed consent that takes into account the emotional component and clearly and completely explains
the possible alternatives and complications associated with possible prosthetic revision surgery.
Level of evidence: Level III, risk/prognostic study
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Introduction
Breast augmentation is the most commonly performed surgi-
cal procedure in aesthetic plastic surgery and implant-based
breast reconstruction is the most popular technique worldwide
in post-mastectomy patients [1–6].
According to the American society of plastic surgeons,
about 400,000 women in the USA alone undergo cosmetic
or reconstructive breast augmentations annually, making the
insertion of silicone implants the most frequently performed
intervention in plastic surgery [7]. In 2017, the total amount of
aesthetic breast augmentation surgeries in USAwas 333,392,
an increase in comparison with 2016 (312,774). In 2018, ap-
proximately 51,000 implants were used in Italy, 63% for aes-
thetic reasons and 37% for reconstructive reasons.
Implant rupture is one of the most important complications
of implant reconstruction, together with capsular contracture.
Implant rupture that can occur from 10 to 15 years from im-
plantation is rarely associated with a traumatic event and rep-
resents the most common cause of prosthesis removal [8, 9].
Symptoms such as change in breast shape, size or firmness,
capsular contracture, palpable lumps or breast pain may lead
to patient evaluation for implant rupture. Clinically significant
signs or symptoms are not presented by most breast implant
rupture patients, who are classified as having “silent” ruptures.
In more than 50% of cases, it is not detected during clinical
examination. The imaging diagnosis of the rupture of the
mammary implant is a frequent consultation and a diagnostic
challenge.
In extracapsular rupture, both the implant shell and the
fibrous capsule are breached, with macroscopic silicone leak-
age into the surrounding tissues or lymph nodes; in the liter-
ature, a high rate of correspondence is reported when breast
ultrasound is used to confirm an extracapsular rupture. As
already reported by numerous authors, the diagnosis of
extracapsular rupture has less false positives than intracapsular
rupture, both when ultrasound and MRI are used [10–12].
In the case of intracapsular rupture, the implant shell is
breached without macroscopic silicone leakage beyond the
intact fibrous capsule. Although there are typical signs at both
ultrasound and MRI [10, 11], there is not a high match be-
tween diagnosis and the actual clinical picture.
The diagnosis of prosthetic rupture may not always appear
as a frank rupture and a diagnosis of “suspected rupture” is
often possible; in such cases, a further in-depth diagnostic
examination is not always required, but the patient may be
advised to consult the plastic surgeon.
The patient does not always receive exhaustive infor-
mation about possible treatment options, the number of
false positives and the risks associated with possible
prosthetic revision surgery.
It is therefore of primary importance to establish an ade-
quate diagnostic-therapeutic procedure to be followed and,
from a medical-legal point of view, a specific and detailed
informed consent based on evidence-based medicine.
Methods
We performed a multicentric retrospective analysis of 183
patients who underwent surgical removal of the prosthesis
due to implant rupture diagnosis between November 2002
and January 2018 in 3 different Plastic Surgery centres
(Centre-North, North-East and Central Italy).
Our research focussed on possible associations between
implant rupture and implant specifications. We examined the
medical history and symptoms of the patients, comparing the
main purpose of radiological investigation and physical exam-
ination at presentation, as well as the side presenting the rup-
tured implant, radiological, surgical and pathological data.
The study followed the principles of the Helsinki declara-
tion and was approved by the local ethics committee.
Imaging
Our study included women who consulted our outpatient
clinics with a radiological diagnosis of suspected breast im-
plant rupture. We analysed 221 prostheses.
These patients underwent a radiological diagnostic exami-
nation for different reasons, such as follow-up/control, pain or
discomfort, deformation or redness or swelling after trauma.
US and MRI examinations were performed in different
radiodiagnostic centres and were analysed by a radiologist
experienced in breast imaging without previous knowledge
of the results of each method and blinded to surgical results.
The results regarding the integrity of the prostheses that
were obtained at the time of the radiodiagnostic investigation
were classified as follows:
– normal implant when the shell presented without loss of
continuity or in the absence of typical signs of prosthetic
rupture
– suspected prosthetic rupture when the prosthetic contour
was altered in the absence of signs of pathognomonic
prosthetic rupture.
– frank rupture of the prosthesis when the shell showed a
loss of continuity with the release of silicone from the
implant
This category (implant rupture) was divided into an
intracapsular rupture (when the silicone remained defined by
the fibrous capsule), an extracapsular rupture (when the sili-
cone was present outside the fibrous capsule in the surround-
ing breast tissue) and intra-extracaspular rupture (when there
were both together).
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Normally, asymptomatic patients were diagnosed with
suspected rupture by ultrasound at a normal follow-up check.
Patients with symptoms or following trauma underwent MRI
directly.
For patients with ultrasound diagnosis of suspected pros-
thetic rupture, the radiologist recommended an in-depth ex-
amination by MRI or a visit to the plastic surgeon.
Clinical examination
During the interviews, we asked the women about their med-
ical history, focussing on comorbidities, chronic medications,
smoking and the age at which they had the implant. Among
the symptoms reported, that led them to consult their doctor to
be assessed for possible implant rupture, were breast pain,
breast deformation or discomfort. We also documented im-
plant data, including the manufacturer, duration, shape, tex-
ture, size and plane of augmentation.
All patients underwent a general physical examination in-
cluding manual examination and measurement of the breast,
while we looked for any signs of possible implant rupture.
We rated the overall aesthetic result and documented any
surgical complications such as capsular contracture, asymme-
try, palpability of the implant and enlargement of the axillary
lymph node. Photographic documentation was also produced,
with anterior and oblique views of the patients standing erect.
After informing the patient about the possible diagnosis
and possible solutions, explaining the pros and cons of the
intervention, the patients were placed on the waiting list with
top priority for prosthetic revision. Written informed consent
was obtained in all cases.
Surgical findings at explantation
After removal, the implants were examined for rupture, clas-
sifying them as ruptured or intact. Implants were considered
normal when the elastomeric envelope was complete without
perforations, also including a silicone gel layer because of
bleeding, while implants in which the elastomer shell present-
ed a lack of continuity were considered ruptured. No implants
suffered damage during removal. As requested by the manu-
facturer, the removed implants were sterilised and returned for
further examination.
Capsule irregularities were documented and, when present,
a capsular biopsy was sent for pathological examination.
Results
Patients’ demographics are reported in Table 1.
The mean age for breast augmentation in women was
42.6 years (IQR 18–74 years) and the mean age at which
breast implant rupture was detected was 54.2 years (IQR
27–86 years).
Seventy-four women underwent breast reconstruction after
mastectomy due to breast carcinoma.
Fifty-four patients were smokers and sixty-nine patients
take drugs.
As we can see in Table 2, the mean duration of implant was
14.1 years (IQR 3–38). Mean implant volume was 329.3 cc
(IQR 120–600).
Implant duration and volume were not statistically corre-
lated with increased rupture rate. Most implants were round;
the plane of augmentation was submuscular in most of the
patients.
Eighty-nine percent of the prostheses were single lumen
(all silicone implants).
The most frequent reasons for these patients to have a ra-
diological examination were for control/follow-up (56%), for
the presence of deformity-asymmetry and redness (25%), for
pain and discomfort (15%) and following accidental trauma at
the breast level (4%).
During the visit with the plastic surgeon, the symptoms
complained of by patients were pain and discomfort (33%),
breast deformation (26%) and redness (5%); 36% of the pa-
tients reported no symptoms.
For radiological diagnosis, ultrasound alone was used in
51% of patients, MRI in 26%, and in 23% of patients MRI
was associated with ultrasound diagnosis.
In 138 cases, a radiological diagnosis of suspected
intracapsular rupture was made, in 68 cases of extracapsular
rupture and in 15 cases of intracapsular and extracapsular
rupture.
One hundred and forty-eight implants were found to be
ruptured during surgery and 73 without rupture at
explantation.
Finally, there were no late seromas (defined as 20 cc of
periprosthetic fluid 6 months after the augmentation
mammoplasty) and none of the capsules sent for pathological
examination was positive for breast carcinoma or anaplastic
large cell lymphoma (ALCL).
Discussion
In 2016, Lotan et al. reported their experience with 109 cases
of implants removed following the diagnosis of suspected
implant rupture [12]; in more than one-third of cases, the im-
plants were not ruptured at removal and had therefore been
unjustifiably removed.
In the literature, this is the largest case study of suspected
implant rupture.
In this sense, our multicentric work confirms what was
previously found: the number of implants removed that did
not show any rupture was 33%. This figure is not uniform in
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the three centres taken into account: in fact, the second hospi-
tal (Centre-North) showed a lower number of false positives
(20%). This may be due to the increased number of diagnoses
of suspected extracapsular ruptures, which we know have
fewer false positives [10–16].
The first centre (North-East), on the other hand, showed a
higher false positive rate than the others (40%); this can be
justified by the use of ultrasound alone (in 55% of cases) as a
diagnostic method in a sample of patients who had mostly
implants below the muscle (97%), therefore less easily assess-
able than subglandular ones.
In the three study centres, ultrasound (51%) was the most
commonly used diagnostic method. This choice is related to
the reason why these patients underwent the radiodiagnostic
examination: in more than half of the patients (56%), it was
performed for annual follow-up/control. In these asymptom-
atic patients, the least expensive screening method was cho-
sen; breast implants were then removed without further
radiodiagnostic examination (MRI). Most of the implants re-
moved and found intact had been evaluated by ultrasound
alone (42%).
Only in 23% of patients was the combination of ultrasound
and MRI used for diagnosis.
The overall accuracy for magnetic resonance imaging was
94%, whereas that for ultrasound was 72% [17, 18]. Although
MRI has a higher specificity and sensitivity and is considered
by many to be the method of choice in such patients [17], it
still has false positives.
In this sense, our work confirms what is already present in
the literature [12, 15, 17]: the number of false positives de-
creases in cases where ultrasound and MRI are associated.
There is a significant cost difference between ultrasound and
MRI, which tends to drive clinical decision making. The choice
of technique mostly depends on the surgeon’s preference, as
there is currently no general agreement in favour of MRI
screening when implant rupture is suspected [18]. There is a
more controversial approach to asymptomatic implant rupture,
preferring a “watchful waiting” strategy. Exchanging the im-
plants of an asymptomatic women, whose breasts have a soft
and satisfactory appearance, exposes them to the risk of poten-
tial complications resulting from surgery. In the case of cosmet-
ic breast implants, the statistics indicate that the risk is low;
Table 1 Patient demographics
Hospital Centre 1 Centre 2 Centre 3 Total
No. of patients 62 64 57 183
Mean patient age at breast
augmentation (range)
47.3 years
(19–74)
42.7 years
(18–53)
37.8 years
(19–49)
42.6 years
Mean patient age at which breast
implant rupture was detected
(range)
56.4 years
(27–86)
51.1 years
(33–71)
55.1 years
(35–80)
54.2 years
Comorbidities
None 31/62 (50%) 48/64 (75%) 29/57 (51%) 108/183
(59%)
Patients with comorbidity
• History of breast cancer 48 6 20 74
• Hypertension 11 8 8 27
• Diabetes mellitus 4 3 2 9
• Hypothyroidism 3 2 4 9
• Fibromyalgia 1 0 0 1
• Celiac 2 2 1 5
• Other 3 4 6 13
31/62 (50%) 16/64 (25%) 28/57 (49%) 75/183
(41%)
Smoking
• Yes 19/62 (31%) 20/64 (31%) 15/57 (26%) 54/183
(30%)
• No 43/62 (69%) 44/64 (69%) 42/57 (74%) 129/183
(70%)
Drugs
• None 36/62 (63%) 48/64 (75%) 30/57 (53%) 114/183
(62%)
• Steroid treatment 2/31 3/16 2/27 69/183
(38%)• Other 24/31 14/16 25/27
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Table 2 Implant specifications, symptoms and surgical plane of augmentation
Hospital Centre 1 Centre 2 Centre 3 Total
Implants suspected of rupture 73 68 80 221
Implant characteristics
Mean duration of implant, years (range) 11.8 years (8–14) 12.7 years (3–30) 17.7 years (4–38) 14.1 years
Mean implant volume, cc (range) 374.9 cc (150–655) 284.4 cc (120–440) 328.7 cc (120–600) 329.3 cc
Purpose of implantation (n)
• Reconstructive 55/73 (75%) 26/68 (38%) 46/80 (57%) 127/221 (57%)
• Aesthetic 18/73 (25%) 42/68 (62%) 34/80 (43%) 94/221 (43%)
Plane of augmentation
• Subglandular 2/73 (3%) 38/68 (56%) 48/80 (60%) 88/221 (40%)
• Submuscular 71/73 (97%) 30/68 (44%) 32/80 (40%) 133/221 (60%)
Implant shape
• Round 32/73 (44%) 57/68 (84%) 39/80 (49%) 128/221 (58%)
• Anatomic 39/73 (53%) 7/68 (10%) 34/80 (42%) 80/221 (36%)
•Unknown 2/73 (3%) 4/68 (6%) 7/80 (9%) 13/221 (6%)
Implant type
• Single lumen 61/73 (84%) 66/68 (97%) 70/80 (87%) 197 (89%)
• Double lumen 12/73 (16%) 2/68 (3%) 10/80 (13%) 24 (11%)
Implant brand
• McGhan 14/73 20/68 9/80 43/221
• Mentor 29/73 3/68 15/80 47/221
• PIP 2/73 2/68 0/80 4/221
• Laboratories Arion 5/73 0/68 3/80 8/221
• Eurosilicone 4/73 0/68 4/80 8/221
• Polytech 1/73 2/68 6/80 9/221
• Inamed corporation 5/73 10/68 0/80 15/221
• Silimed 5/73 2/68 0/80 7/221
• Nagor 3/73 0/68 2/80 5/221
• Allergan 3/73 19/68 25/80 47/221
• Koken 0/73 0/68 2/80 2/221
• Dow Corning 0/73 2/68 0/80 2/221
• Sebin 0/73 0/73 5/80 5/221
• Unknown 2/73 8/68 9/80 19/221
Implant position
• Left 41/73 (56%) 29/68 (43%) 26/80 (33%) 96/221 (43%)
• Right 32/73 (44%) 39/68 (57%) 54/80 (67%) 125/221 (57%)
Main purpose of radiological investigation
• Follow-up/control 38/62 (61%) 34/64 (53%) 31/57 (54%) 103/183 (56%)
• Pain/discomfort 8/62 (13%) 9/64 (14%) 10/57 (18%) 27/183 (15%)
• Deformation/asymmetry/redness/swelling 14/62 (22%) 17/64 (26%) 15/57 (26%) 46/183 (25%)
• Trauma 2/62 (4%) 4/64 (6%) 1/57 (2%) 7/183 (4%)
Subject’s reported symptoms during visit
• Asymptomatic 14/62 (22%) 28/64 (44%) 23/57 (40%) 65/183 (36%)
• Pain/discomfort 28/62 (45%) 19/64 (30%) 14/57 (25%) 61/183 (33%)
• Deformation 16/62 (26%) 15/64 (23%) 17/57 (30%) 48/183 (26%)
• Redness 4/62 (7%) 2/64 (3%) 3/57 (5%) 9/183 (5%)
Evaluation of implant integrity
Ultrasonography 40/73 (55%) 27/68 (40%) 45/80 (56%) 112/221 (51%)
Magnetic resonance imaging 25/73 (34%) 20/68 (29%) 13/80 (16%) 58/221 (26%)
Ultrasonography + magnetic resonance imaging 8/73 (11%) 21/68 (31%) 22/80 (28%) 51/221 (23%)
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however, the incidence of complications is known to be higher
in revision surgery than in primary surgery.
We have therefore developed a decisional algorithm that
should guide every surgeon in the diagnostic therapeutic pro-
cess avoiding, or at least decreasing, the number of false pos-
itives (see Fig. 1).
This algorithm takes into account the reason for the investi-
gation, the presence of symptoms, the use of ultrasound orMRI
for the diagnosis and the psychological aspect of the patient.
The emotional picture of women diagnosed with a
“suspected implant rupture” during a normal follow-up check
(in most cases, therefore, asymptomatic) should not be
underestimated as this can influence the diagnosis and, there-
fore, the subsequent therapeutic procedure [17].
Our multicentric study confirms how the psychological
picture of the patient can influence the surgeon’s decision on
the diagnostic-therapeutic procedure to be undertaken [17]. In
fact, although 56% of the patients had undergone a radiolog-
ical examination for control/follow-up (so they are presumed
to be asymptomatic) and only 15% for pain and discomfort,
during the consultation with the plastic surgeon (following the
radiological diagnosis), the symptoms complained of by the
patients were pain and discomfort in 33%, while only 36% of
the patients reported no pain.
This increase in the number of symptomatic patients be-
tween the radiological investigation and the consultation with
the plastic surgeon seems to be due to the onset of fear that
turns into psychological pain; this pain, if it is not processed
and persists, can somatise and turn into physical pain. All this
can induce the surgeon to make a clear decision about pros-
thetic revision surgery.
Therefore, since many factors have to be taken into consid-
eration in the diagnosis and treatment of these patients, it
seems necessary (from a medical/legal point of view) to have
a wide and exhaustive interview with the patient that allows
her to receive correct and ample information in order to be
able to make a judicious choice about the Evidence Base
Practice, a choice that is informed and not determined by the
fear and emotions of the moment.
It is essential to submit to the patient an appropriate and
specific informed consent form using Evidence Based
Medicine (EBM) [19].
A model of informed consent
Given the absence in the literature of ad hoc consents for
patients with suspected intracapsular implant rupture, we have
drawn up a prospectus and consent form based on the results
obtained and on what is present in the literature (see Annex 1).
This consent form has different sections: in the first part,
there is an informed prospectus describing the advantages
(and possible complications) of a watchful wait, i.e. carrying
out close clinical-radiological checks.
Based on EBM, a watchful wait in asymptomatic pa-
tients appears justified. In fact, as Holmich et al. suggested,
implant rupture is a harmless event that does not seem to
produce significant clinical symptoms or activate the hu-
moral immune system, and only in rare cases may give rise
to severe local problems, at least within a period of 2 years
[11]. So, their findings do not support the view that explan-
tation surgery is mandatory in asymptomatic women.
However, because there appears to be a small risk of pro-
gression of free silicone migration, they suggested that
women with asymptomatic implant rupture be followed
with regular clinical examinations, including evaluation
of specific signs of silicone migration [11].
The second part describes the possible psychological con-
sequences for patients with a diagnosis of suspected
intracapsular implant rupture. The risks associated with the
development of a somatoform disorder justify the need for
psychological counselling; therefore, the possibility of an in-
terview with expert psychologists is made available.
Finally, in the last part of the informed consent form, the
other possible option is prosthetic revision surgery: from the
Table 2 (continued)
Hospital Centre 1 Centre 2 Centre 3 Total
Implants suspected of rupture 73 68 80 221
Diagnosis of:
• Suspected intracapsular rupture 59/73 (81%) 33/68 (49%) 46/80 (56%) 138/221 (62%)
• Suspected extracapsular rupture 11/73 (15%) 32/68 (47%) 25/80 (31%) 68/221 (31%)
• Suspected intra-extracapsular rupture 3/73 (4%) 3/68 (4%) 9/80 (11%) 15/221 (7%)
Findings at explantation
Number of implants with rupture at explantation 44/73 (60%) 55/68 (80%) 49/80 (61%) 148/221 (67%)
Number of implants without rupture at explantation 29/73 (40%) 13/68 (20%) 31/80 (39%) 73/221 (33%)
• US-suspected implants were found intact when explanted 18/40 7/30 23/45 48/115
• RM-suspected implants were found intact when explanted 9/25 4/20 5/13 18/58
• US+RM-suspected implants were found intact when explanted 2/8 2/18 3/22 7/48
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accurate description of the procedure to the possible related
complications, emphasizing that the final aesthetic result may
not meet expectations.
The current study is not exempt from limitations.
The limitations of this study are mainly represented by the
retrospective design of the study; clinical and radiological
evaluations are highly physician-dependent; all examinations
were not performed at the same radiologic centre and all US
and MRI images not were read by the same reader.
Conclusions
In the case of extracapsular rupture US diagnosis, surgical
implant removal could be proposed without further
investigations.
In case of intracapsular rupture, if US indicates a possible
rupture, it should be investigated with MRI, which offers
greater sensitivity. If doubt persists, it is of primary importance
to inform the patient of the advantages/disadvantages of
performing a close clinical radiological follow-up, as well as
psychological counselling if considered useful.
Adequate informed consent, which is as broad and specific
as possible, is necessary in this area, both to enable the patient
to participate in the choice of therapeutic procedure, and to
avoid possible legal disputes related to any complications
resulting from unnecessary intervention.
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EBM: evidence based medicine
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Fig. 1 Decision and management algorithm flowchart. Various reasons
could lead the patient to carry out a radiodiagnostic check: for the onset of
symptoms after a trauma, in asymptomatic patients for a normal check/
follow-up, for the onset of breast asymmetry, for the presence of other
signs at breast level such as swelling and redness. Normally,
asymptomatic patients were diagnosed with suspected rupture by
ultrasound at a normal follow-up check. Patients with symptoms or fol-
lowing trauma underwent MRI directly. If this test does not confirm a
frank rupture, it must be supplemented with another radiodiagnostic test.
If the rupture is confirmed, prosthetic revision surgery will be indicated.
In the event that radiodiagnostic doubt remains and the patient is symp-
tomatic, a doctor-patient interview associated with specific informed con-
sent based on EBM will allow the patient to choose the procedure to
follow. If the patient is asymptomatic, she will be advised to carry out
radiodiagnostic checks every 6 months (or earlier if the clinical picture
changes). If the patient complains of symptoms during subsequent exam-
inations, it is advisable to recommend psychological counselling.
Subsequently, a doctor-patient interview associated with a specific in-
formed consent based on EBM will make the patient aware of the pros
and cons of possible surgery
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